share_log

6-K: Block Listing Application

6-K: Block Listing Application

6-K:整批上市申請
美股SEC公告 ·  2024/12/20 15:40

牛牛AI助理已提取核心訊息

GSK plc has submitted a block listing application to the Financial Conduct Authority and London Stock Exchange for 700,000 ordinary shares with a nominal value of 31¼p each. These shares are specifically reserved for issuance under the GlaxoSmithKline plc Share Save Plan 2012, an employee share scheme.The new shares, upon issuance, will carry equal rights with existing ordinary shares of the same class. The admission of these shares to the Official List is anticipated to become effective on December 23, 2024.
GSK plc has submitted a block listing application to the Financial Conduct Authority and London Stock Exchange for 700,000 ordinary shares with a nominal value of 31¼p each. These shares are specifically reserved for issuance under the GlaxoSmithKline plc Share Save Plan 2012, an employee share scheme.The new shares, upon issuance, will carry equal rights with existing ordinary shares of the same class. The admission of these shares to the Official List is anticipated to become effective on December 23, 2024.
葛蘭素史克公司已向金融行爲監管局和倫敦交易所提交了70萬個普通股的區塊上市申請,每股名義價值爲31¼便士。這些股份專門保留用於在葛蘭素史克股份儲蓄計劃2012下發行,該計劃爲員工股份計劃。新發行的股份將在權益上與同類現有普通股享有平等待遇。這些股份的上市預計將於2024年12月23日生效。
葛蘭素史克公司已向金融行爲監管局和倫敦交易所提交了70萬個普通股的區塊上市申請,每股名義價值爲31¼便士。這些股份專門保留用於在葛蘭素史克股份儲蓄計劃2012下發行,該計劃爲員工股份計劃。新發行的股份將在權益上與同類現有普通股享有平等待遇。這些股份的上市預計將於2024年12月23日生效。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
評論 評論 · 瀏覽 217

熱點推薦

聲明

本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠,亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。